Minimal Residual Disease Surveillance in Chronic Lymphocytic Leukemia by Fluorescence-Activated Cell Sorting
Achievement of complete response (CR) to therapy in chronic lymphocytic leukemia (CLL) has become a feasible goal, directly correlating with prolonged survival. It has been established that the classic definition of CR actually encompasses a variety of disease loads, and more sensitive multiparamete...
Main Authors: | Shimrit Ringelstein-Harlev, Riva Fineman |
---|---|
Format: | Article |
Language: | English |
Published: |
Rambam Health Care Campus
2014-10-01
|
Series: | Rambam Maimonides Medical Journal |
Subjects: | |
Online Access: | http://rmmj.org.il/Pages/ArticleHTM.aspx?manuId=446 |
Similar Items
-
Chronic Lymphocytic Leukemia: Prognostic Significance of Minimal Residual Disease and Potential of Modern Methods of Its Diagnosis and Therapy (Literature Review)
by: AYu Kuvshinov, et al.
Published: (2016-04-01) -
Minimal Residual Disease in Chronic Lymphocytic Leukemia: A New Goal?
by: Ilaria Del Giudice, et al.
Published: (2019-08-01) -
Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
by: A. M. Popov, et al.
Published: (2015-12-01) -
Highly Sensitive and Accurate Assessment of Minimal Residual Disease in Chronic Lymphocytic Leukemia Using the Novel CD160-ROR1 Assay
by: Timothy W. Farren, et al.
Published: (2020-12-01) -
Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
by: Maura Rosane Valério Ikoma, et al.
Published: (2015-12-01)